BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21258405)

  • 1. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells.
    Merlin J; Stechly L; de Beaucé S; Monté D; Leteurtre E; van Seuningen I; Huet G; Pigny P
    Oncogene; 2011 Jun; 30(22):2514-25. PubMed ID: 21258405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking.
    de Oliveira JT; de Matos AJ; Santos AL; Pinto R; Gomes J; Hespanhol V; Chammas R; Manninen A; Bernardes ES; Albuquerque Reis C; Rutteman G; Gärtner F
    Int J Dev Biol; 2011; 55(7-9):823-34. PubMed ID: 22161838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-MUC1 antibody inhibits EGF receptor signaling in cancer cells.
    Hisatsune A; Nakayama H; Kawasaki M; Horie I; Miyata T; Isohama Y; Kim KC; Katsuki H
    Biochem Biophys Res Commun; 2011 Feb; 405(3):377-81. PubMed ID: 21219855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
    Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
    Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
    Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
    Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.
    Roda O; Ortiz-Zapater E; Martínez-Bosch N; Gutiérrez-Gallego R; Vila-Perelló M; Ampurdanés C; Gabius HJ; André S; Andreu D; Real FX; Navarro P
    Gastroenterology; 2009 Apr; 136(4):1379-90, e1-5. PubMed ID: 19171142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC1 intra-cellular trafficking is clathrin, dynamin, and rab5 dependent.
    Liu X; Yuan Z; Chung M
    Biochem Biophys Res Commun; 2008 Nov; 376(4):688-93. PubMed ID: 18812166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of MUC1 in advanced pancreatic cancer.
    Hinoda Y; Ikematsu Y; Horinochi M; Sato S; Yamamoto K; Nakano T; Fukui M; Suehiro Y; Hamanaka Y; Nishikawa Y; Kida H; Waki S; Oka M; Imai K; Yonezawa S
    J Gastroenterol; 2003; 38(12):1162-6. PubMed ID: 14714254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of translocation of tight junction protein Zonula occludens-1 and activation of epidermal growth factor receptor in the regulation of invasion of pancreatic cancer cells.
    Takai E; Tan X; Tamori Y; Hirota M; Egami H; Ogawa M
    Int J Oncol; 2005 Sep; 27(3):645-51. PubMed ID: 16077912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
    Tobita K; Kijima H; Dowaki S; Kashiwagi H; Ohtani Y; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2003 Mar; 11(3):305-9. PubMed ID: 12579331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor.
    Ozaki N; Ohmuraya M; Hirota M; Ida S; Wang J; Takamori H; Higashiyama S; Baba H; Yamamura K
    Mol Cancer Res; 2009 Sep; 7(9):1572-81. PubMed ID: 19737965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop.
    Ramasamy S; Duraisamy S; Barbashov S; Kawano T; Kharbanda S; Kufe D
    Mol Cell; 2007 Sep; 27(6):992-1004. PubMed ID: 17889671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an in vitro study on the microenvironment of pancreatic ductal adenocarcinoma.
    Xue X; Lu Z; Tang D; Yao J; An Y; Wu J; Li Q; Gao W; Xu Z; Qian Z; Dai C; Wei J; Miao Y; Jiang K
    Pancreas; 2011 Aug; 40(6):832-9. PubMed ID: 21747316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid can induce markers of endocrine transdifferentiation in pancreatic ductal adenocarcinoma: preliminary observations from an in vitro cell line model.
    El-Metwally TH; Hussein MR; Abd-El-Ghaffar SKh; Abo-El-Naga MM; Ulrich AB; Pour PM
    J Clin Pathol; 2006 Jun; 59(6):603-10. PubMed ID: 16473924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells.
    Piyush T; Chacko AR; Sindrewicz P; Hilkens J; Rhodes JM; Yu LG
    Cell Death Differ; 2017 Nov; 24(11):1937-1947. PubMed ID: 28731466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
    Yonezawa S; Nakamura A; Horinouchi M; Sato E
    J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
    Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
    Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
    Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
    Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation.
    Yuan Z; Wong S; Borrelli A; Chung MA
    Biochem Biophys Res Commun; 2007 Oct; 362(3):740-6. PubMed ID: 17764657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.
    Liu N; Furukawa T; Kobari M; Tsao MS
    Am J Pathol; 1998 Jul; 153(1):263-9. PubMed ID: 9665487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.